← FDA Drug Approvals (Drugs@FDA)
GABAPENTIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2006-08-18
Drug application
- FDA Application #
ANDA077662- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- GABAPENTIN
- Generic name
- GABAPENTIN
- Active ingredients
- GABAPENTIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- GLENMARK PHARMS LTD
- Manufacturer
- BluePoint Laboratories
- First approval
- 2006-08-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown